Biosimilar Supply Landscape

As the market for Bio-similar products continues to grow, many Biopharmaceutical companies are trying to enter this space. Biopharmaceutical companies need to overcome the unique challenges that developing such products presents: navigating the complex global regulatory landscapes to ensuring optimal suppliers for various development work. Clinical research organizations (CROs) with experience in biologics and robust regulatory departments, and outside regulatory consultants with specific knowledge can play a crucial role in assisting companies as they endeavor to develop Bio-similar products.